1205 Amber Drive
Suite 210
Thunder Bay, ON P7B 6M4
Canada
844 730 9822
https://www.zentek.com
Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Francis Dube B.Sc. | Exec. Chairman | 181.62k | N/A | N/A |
Mr. Gregory Fenton C.F.A. | CEO & Director | 137.5k | N/A | N/A |
Dr. Colin van der Kuur B.Sc., DMIN | VP of Science & Research | 74.89k | N/A | N/A |
Ms. Wendy Ford CA, CPA | Chief Financial Officer | N/A | N/A | N/A |
Mr. Ryan Shacklock | VP of Strategy, Bus. Devel. & Investor Relations | N/A | N/A | N/A |
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite Project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating; and surgical masks, HVAC filters, and personal protective equipment. It is also developing synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is based in Thunder Bay, Canada.
Zentek Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.